Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients

Clinical trial NCT00057447 · TERMINATED

Trial details

NCT number: NCT00057447
Sponsor: InterMune
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma

Start date: 2003-03-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.